Injectable lipolytic (fat-dissolving) solution
A South Korean fat-dissolving injectable marketed to break down localized pockets of fat.
| Class / type | Injectable lipolytic (fat-dissolving) solution |
|---|---|
| Category | Metabolic & Weight |
| Status (Jul 2026) | Research use only |
Contains bromelain, lecithin (phosphatidylcholine), and riboflavin, which are claimed to break down and emulsify fat cells at the injection site for reabsorption.
Used cosmetically in aesthetic clinics for localized fat reduction (chin, arms, abdomen).
Reported to reduce small, stubborn fat pockets with minimal downtime and is popular through social media promotion.
Lacks large-scale clinical trials, is unregulated in the US, and can cause swelling, bruising, pain, and infection risk from an unverified formulation.
Users report visible localized fat reduction and quick recovery, but this sentiment is anecdotal and not backed by rigorous data.
NOT FDA-approved: not FDA- or CE-approved; sold as an unregulated cosmetic product with Kybella being the only FDA-approved injectable fat dissolver as of 2026.